FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Darifenacin Hydrobromide Tablets
Status: Discontinuation
»Therapeutic Categories: Urology

Expand all

Par Pharmaceutical (New 10/30/2019)

Company Contact Information:
800-828-9393

Presentation Posting Date Related Information
Extended-Release Tablet, 15 mg Bottle of 30, (NDC 10370-171-11) 10/30/2019 Par has made a business decision to permanently discontinue the drug product.
Extended-Release Tablet, 15 mg Bottle of 90 (NDC 10370-171-09) 10/30/2019 Par has made a business decision to permanently discontinue the drug product.
Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 10370-170-11) 10/30/2019 Par has made a business decision to permanently discontinue the drug product.
Extended-Release Tablet, 7.5 mg Bottle of 90 (NDC 10370-170-09) 10/30/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English